Organisation paid for research Program year 2025 Source: CMS Open Payments

Physicians Research Group II, LLC

Neither a doctor nor a teaching hospital

Research payments

$837,590

69 payments

Through program year 2025, Physicians Research Group II, LLC is reported as receiving $837,590 in research payments, across 69 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$36,125	8
2024	Research	$306,910	20
2023	Research	$86,860	9
2022	Research	$159,842	15
2021	Research	$38,898	10
2020	Research	$208,075	6
2019	Research	$880	1

Breakdown

Who paid Research payments · program years 2019–2025

Anika Therapeutics, Inc. $314,250 12 payments
IBSA Institut Biochimique SA $276,550 16 payments
Avita Medical Americas, LLC $138,465 14 payments
Almirall LLC $61,016 10 payments
Globus Medical, Inc. $44,300 11 payments
Zimmer Biomet Holdings, Inc. $1,920 2 payments
Alcon Research LLC $1,089 4 payments

Studies the money was for Research payments · program years 2019–2025

PROGRESS - Subcutaneous PROgesterone in fRozen-thawed single Euploid blaStocyst tranSfer $276,550 16 payments
A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast With BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control $168,775 3 payments
A Prospective, Randomized, Active Treatment-controlled, Evaluator-blinded Multicenter Study to Establish the Superiority of Hyalofast With BMAC in the Treatment of Articular Knee Cartilage Defect Lesions in Comparison to Control $140,476 8 payments
A Prospective Post-Market Clinical Study Investigating Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin Cells $68,980 1 payment
M14867-32 $61,016 10 payments
Aminos RT $44,300 11 payments
A Prospective Post-Market Clinical Study Investigating Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells $27,595 4 payments
A Prospective Post-Market Clinical Study Investigating Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin Cells $21,635 5 payments
CTP010 Additional Vitiligo Study $20,255 4 payments
A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined With Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee $5,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.